Back to Search
Start Over
Intrathecal neurolysis for the management of refractory pain in a patient with terminal oncological disease: case report.
- Source :
-
Pain management [Pain Manag] 2022 Jul; Vol. 12 (5), pp. 569-577. Date of Electronic Publication: 2022 Mar 17. - Publication Year :
- 2022
-
Abstract
- We report on the successful treatment of refractory cancer pain by intrathecal neurolysis using 96% absolute alcohol. A female patient with colorectal adenocarcinoma with metastases to the sacral bones, the patient had severe pain refractory to pharmacological and interventional treatment. Intrathecal neurolytic block at the L5-S1 intervertebral space was performed, she reported a significant improvement in her pain and decreased opioid use. The patient did not show deterioration of neurological functions after the procedure or associated complications, and outpatient treatment continued with a home medicine program. She remained comfortable until her death 6 weeks later. Considering that this is an accessible and cost-effective procedure, it could be a helpful alternative for the management of patients with refractory pain in the terminal stage.
Details
- Language :
- English
- ISSN :
- 1758-1877
- Volume :
- 12
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Pain management
- Publication Type :
- Academic Journal
- Accession number :
- 35297268
- Full Text :
- https://doi.org/10.2217/pmt-2021-0097